KAPA
Kairos Pharma (KAPA)
NYSE
$1.80+$0.04 (+2.39%)
Price as of Sep 11, 2026 7:56 PM EDT
  • $6.0M
    Market Cap
  • -85.73%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

N/A
No data found

No data found

Momentum Score

Score: 56
Valuation
KAPA
vs History
vs S&P 500
3-Month Momentum
-17.73%
12-Month Momentum
-80.30%
3-Month Risk Adjusted Momentum
-44.73%
12-Month Risk Adjusted Momentum
-100.70%

True Yield

N/A
No data found

No data found

Financial Health Score

N/A
No data found

No data found